TCM
ABVX

TCG Crossover Management’s Abivax ABVX Stock Holding History

TCG Crossover Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$722M Sell
6,481,085
-630,511
-9% -$74.6M 20.65% 1
2025
Q4 		$959M Hold
7,111,596
– – 31.74% 1
2025
Q3 		$604M Buy
7,111,596
+1,055,000
+17% +$64.7M 29.7% 1
2025
Q2 		$46.3M Hold
6,056,596
– – 5.29% 6
2025
Q1 		$37.9M Hold
6,056,596
– – 5.16% 6
2024
Q4 		$44.3M Hold
6,056,596
– – 4.33% 8
2024
Q3 		$69.8M Hold
6,056,596
– – 5.91% 4
2024
Q2 		$80.1M Buy
6,056,596
+4,956,596
+451% +$70.9M 8.34% 3
2024
Q1 		$15.7M Hold
1,100,000
– – 1.24% 24
2023
Q4 		$11.8M Buy
+1,100,000
New +$11.2M 1.31% 22

Other funds holding ABVX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return